Timiperone
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 1-(4-fluorophenyl)-4-[4-(2-thioxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]butan-1-one | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | Oral |
| Identifiers | |
| CAS number | 57648-21-2 |
| ATC code | None |
| PubChem | CID 3033151 |
| UNII | 626DQ7N19L |
| KEGG | D02035 |
| Chemical data | |
| Formula | C22H24FN3OS |
| Mol. mass | 397.50 g/mol |
| SMILES | eMolecules & PubChem |
| |
Timiperone is an antipsychotic.[1][2]
[edit] References
- ^ Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties., Arzneimittelforschung. 1981;31(4):707-15, PMID: 6113834 PubMed - indexed for MEDLINE
- ^ Effect of Timiperone, a New Antipsychotic Drug, on the Sleep-Wakefulness Cycle in Cats, The Japanese Journal of Pharmacology, Vol.39 , No.3(1985)pp.391-394
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

